Victory Capital Management Inc. Acquires 49,355 Shares of SIGA Technologies, Inc. (NASDAQ:SIGA)

Victory Capital Management Inc. lifted its stake in SIGA Technologies, Inc. (NASDAQ:SIGA) by 19.0% during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The institutional investor owned 308,498 shares of the company’s stock after purchasing an additional 49,355 shares during the quarter. Victory Capital Management Inc. owned about 0.43% of SIGA Technologies worth $1,854,000 as of its most recent filing with the Securities & Exchange Commission.

Several other hedge funds and other institutional investors also recently made changes to their positions in SIGA. Larson Financial Group LLC purchased a new position in SIGA Technologies during the third quarter valued at $30,000. EP Wealth Advisors LLC bought a new position in shares of SIGA Technologies during the third quarter valued at $82,000. XTX Topco Ltd bought a new position in shares of SIGA Technologies during the third quarter valued at $85,000. Intech Investment Management LLC purchased a new position in shares of SIGA Technologies in the 3rd quarter worth about $120,000. Finally, Bailard Inc. boosted its stake in SIGA Technologies by 31.5% in the 4th quarter. Bailard Inc. now owns 18,800 shares of the company’s stock worth $113,000 after purchasing an additional 4,500 shares in the last quarter. Hedge funds and other institutional investors own 55.40% of the company’s stock.

SIGA Technologies Stock Performance

Shares of SIGA stock opened at $5.63 on Tuesday. The company has a market capitalization of $402.19 million, a price-to-earnings ratio of 4.69 and a beta of 0.98. SIGA Technologies, Inc. has a one year low of $5.16 and a one year high of $12.83. The company’s 50-day moving average is $5.96 and its 200 day moving average is $6.60.

SIGA Technologies (NASDAQ:SIGA) last posted its quarterly earnings results on Tuesday, March 11th. The company reported $0.63 EPS for the quarter. SIGA Technologies had a net margin of 49.33% and a return on equity of 49.06%. The firm had revenue of $81.40 million for the quarter. As a group, research analysts predict that SIGA Technologies, Inc. will post 1.04 earnings per share for the current fiscal year.

SIGA Technologies Company Profile

SIGA Technologies, Inc, a commercial-stage pharmaceutical company, focuses on the health security related markets in the United States. Its lead product is TPOXX, an oral formulation antiviral drug for the treatment of human smallpox disease caused by variola virus. The company was incorporated in 1995 and is headquartered in New York, New York.